College of Pharmacy, State Key Laboratory of Biotherapy, Sichuan University, No. 17, Section 3, Renmin Nan Road, Chengdu 610041, PR China.
Int J Pharm. 2012 Jul 15;431(1-2):210-21. doi: 10.1016/j.ijpharm.2012.04.046. Epub 2012 Apr 23.
In the purpose of increasing incorporation efficiency and improving the release kinetics of plasmid DNA (pDNA) from poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles, a facile method for the fabrication of calcium phosphate (CaPi) embedded PLGA nanoparticles (CaPi-pDNA-PLGA-NPs) was developed. The effect of several preparation factors on the particle size, incorporation efficiency, pDNA release and transfection efficiency in vitro was studied by Single Factor Screening Method. These preparation factors included the molecular weight (MW), hydrolysis degree (HD) of polyvinyl alcohol (PVA), sonication power and time, composition of organic phase, initial concentration of calcium phosphate and calcium (Ca) to phosphate ion (P) ratio (Ca/P ratio), etc. The CaPi-pDNA-PLGA-NPs made according to the optimal formulation were spherical in shape observed by transmission electron microscopy (TEM) with a mean particle size of 207±5 nm and an entrapment efficiency of 95.7±0.8%. Differential scanning calorimetry (DSC) suggested that there existed interaction between the DNA-calcium-phosphate (CaPi-pDNA) complexes and the polymeric matrices of PLGA. X-ray diffractometry (XRD) further proved the conclusion and indicated that the CaPi-pDNA was in weak crystallization form inside the nanoparticles. The Brunauer-Emmett-Teller (BET) surface area measurement demonstrated that the CaPi-pDNA-PLGA-NPs are mesoporous with specific surface area of 57.5m(2)/g and an average pore size of 96.5 Å. The transfection efficiency of the CaPi-pDNA-PLGA-NPs on human embryonic kidney 293 (HEK 293) cells in vitro was 22.4±1.2%, which was much higher than those of both the pDNA loaded PLGA nanoparticles (pDNA-PLGA-NPs) and the CaPi-pDNA embedded PLGA microparticles (CaPi-pDNA-PLGA-MPs). The CaPi-pDNA-PLGA-NPs are promising vectors for gene delivery.
为了提高质粒 DNA(pDNA)从聚(D,L-乳酸-共-乙醇酸)(PLGA)纳米粒中的包封效率和释放动力学,开发了一种简便的制备嵌入磷酸钙(CaPi)的 PLGA 纳米粒(CaPi-pDNA-PLGA-NPs)的方法。通过单因素筛选法研究了几种制备因素对粒径、包封效率、pDNA 释放和体外转染效率的影响。这些制备因素包括聚乙烯醇(PVA)的分子量(MW)、水解度(HD)、超声功率和时间、有机相组成、磷酸钙和钙(Ca)初始浓度以及钙/磷(Ca/P)比等。根据最佳配方制备的 CaPi-pDNA-PLGA-NPs 呈球形,透射电子显微镜(TEM)观察平均粒径为 207±5nm,包封效率为 95.7±0.8%。差示扫描量热法(DSC)表明,DNA-磷酸钙(CaPi-pDNA)复合物与 PLGA 聚合物基质之间存在相互作用。X 射线衍射(XRD)进一步证实了这一结论,并表明 CaPi-pDNA 在内纳米粒中呈弱结晶形式。BET 比表面积测量表明,CaPi-pDNA-PLGA-NPs 是介孔的,比表面积为 57.5m(2)/g,平均孔径为 96.5Å。体外人胚肾 293(HEK 293)细胞中 CaPi-pDNA-PLGA-NPs 的转染效率为 22.4±1.2%,明显高于负载 pDNA 的 PLGA 纳米粒(pDNA-PLGA-NPs)和嵌入磷酸钙的 PLGA 微球(CaPi-pDNA-PLGA-MPs)。CaPi-pDNA-PLGA-NPs 是一种很有前途的基因传递载体。